Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-25-004877·Avidity Partners Management LP
Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 21077P108
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avidity Partners Management LP
Shares: 9,126,176.00 · Class: 9.9%
- Avidity Partners Management (GP) LLC
Shares: 9,126,176.00 · Class: 9.9%
- Avidity Capital Partners Fund (GP) LP
Shares: 9,126,176.00 · Class: 9.9%
- Avidity Capital Partners (GP) LLC
Shares: 9,126,176.00 · Class: 9.9%
- Avidity Master Fund LP
Shares: 5,183,700.00 · Class: 5.6%
- Avidity Private Master Fund I LP
Shares: 7,776,296.00 · Class: 8.4%
- Michael Gregory
Shares: 9,126,176.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-004877
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership